Further processing options
276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy
Saved in:
Journal Title: | Molecular Therapy |
---|---|
Authors and Corporations: | , , , , , , , |
In: | Molecular Therapy, 24, 2016, p. S110 |
Type of Resource: | E-Article |
Language: | English |
published: |
Elsevier BV
|
Subjects: |